This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0090U for the myPath® Melanoma test from Castle Biosciences Inc., which uses RT–PCR mRNA gene expression profiling technology to analyze a biopsy specimen of a lesion suspicious for malignant melanoma for 23 genes and reports the results as benign, intermediate, or malignant.
For clinical responsibility, terminology, tips and additional info
start codify free trial.